Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging, today announced the opening…
Year: 2021
CTI BioPharma Announces Extension of FDA Review Period for Pacritinib in Myelofibrosis with Severe Thrombocytopenia
CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has extended the…
Another Strong Exit for HealthEdge Investment Partners with Sale of The Columbus Organization to CareSource
HealthEdge Investment Partners (“HealthEdge”), a Tampa-FL based private equity fund focused on lower middle market healthcare companies, continues…
nference Study Produces First Molecular Hypothesis Explaining COVID-19-Induced Myocarditis
nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the…
Aditum Bio announces the appointment of Stephen Kanes, M.D. Ph.D., as Chief Executive Officer of Ancora Bio
Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President…
BERG Presents New Research on Potential Therapeutic Path to Fight Huntington’s Disease at The Society for Neuroscience (SfN) Annual Meeting
BERG, the clinical stage biotech that employs patient biology and artificial intelligence (AI) to research diseases…
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., (NASDAQ: HOTH) a patient focused biopharmaceutical company, announced today that it has entered into two…
Diamond Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Low-Dose Psilocybin
Diamond Therapeutics Inc. (“Diamond”), a drug development company focused on non-hallucinogenic, psychedelic-based therapies for use in…
Medical Cannabis Market to Reach $53.88 Bn, Globally, by 2030 at 23.6% CAGR: Allied Market Research
Allied Market Research published a report, titled, “Medical Cannabis Market by Product Type (Buds/Marijuana Flower and Cannabis Extracts),…
AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman…